KIA
UTHR icon

King Investment Advisors’s United Therapeutics UTHR Stock Holding History

King Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,530
Closed -$204K – 17
2015
Q3 		$204K Sell
1,530
-2,550
-63% -$409K 1.38% 22
2015
Q2 		$701K Sell
4,080
-22,590
-85% -$4.06M 1.61% 26
2015
Q1 		$4.59M Sell
26,670
-28,040
-51% -$4.27M 2.19% 19
2014
Q4 		$7.08M Buy
54,710
+855
+2% +$110K 3.16% 8
2014
Q3 		$6.93M Sell
53,855
-1,125
-2% -$116K 3.15% 8
2014
Q2 		$4.87M Sell
54,980
-555
-1% -$53.4K 2.07% 22
2014
Q1 		$5.22M Sell
55,535
-545
-1% -$55.7K 2.39% 20
2013
Q4 		$6.34M Buy
56,080
+48,410
+631% +$4.37M 2.9% 11
2013
Q3 		$605K Buy
+7,670
New +$561K 0.26% 76

Other funds holding UTHR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

King Investment Advisors's UTHR Position: Q4 2015 in Review

King Investment Advisors sold out of United Therapeutics (UTHR) in Q4 2015, closing a stake of 1,530 shares — an estimated $204K sold.

King Investment Advisors first reported a position in UTHR in Q3 2013 and held it in 9 quarters. The position peaked at $7.08M in Q4 2014. 386 funds tracked by Wall St. Rank hold UTHR as of Q4 2015.

  • King Investment Advisors reported no remaining United Therapeutics position as of Q4 2015 after selling out during the quarter.
  • King Investment Advisors sold 1,530 United Therapeutics shares in Q4 2015, an estimated $204K.
  • King Investment Advisors first reported a position in United Therapeutics in Q3 2013 and held it in 9 quarters.
  • King Investment Advisors's United Therapeutics position peaked at $7.08M in Q4 2014.
  • 386 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2015.

Based on King Investment Advisors's 13F filing for Q4 2015, filed 29 Jan 2016.